- Inflammatory bowel disease and cancer risk
- Screening for colorectal cancer
- Registry based research
- Guideline development
- Risk stratification and risk perception.
Lise Mørkved Helsingen is a MD and a PhD candidate in the Clinical Effectiveness Research Group at the University of Oslo and Oslo university Hospital.
The academic year of 2018/2019 she is a visiting student researcher at the Harvard T.H. Chan School of Public Health in Boston, USA.
She is a former medical editor at the Journal of The Norwegian Medical Association.